特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
920709

消化性潰瘍治療薬の世界市場 - 規模、シェア、見通し、機会分析:2019年~2027年

Peptic Ulcer Drugs Market, By Product Type, By Disease Indication, By Distribution Channel, By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 204 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
消化性潰瘍治療薬の世界市場 - 規模、シェア、見通し、機会分析:2019年~2027年
出版日: 2020年01月02日
発行: Coherent Market Insights
ページ情報: 英文 204 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

消化性潰瘍には、胃潰瘍と十二指腸潰瘍の2種類があります。胃潰瘍は胃の内壁によく見られますが、十二指腸潰瘍は小腸に形成されます。消化性潰瘍は、胃を消化液から保護する粘液層の減少が原因で発生します。消化性潰瘍の主な症状は、げっぷ、吐き気、嘔吐、食欲不振などです。消化性潰瘍の治療は潰瘍の種類によって異なり、治療計画は主にプロトンポンプ阻害薬と抗生物質で構成されます。

当レポートでは、世界の消化性潰瘍治療薬市場について調査分析し、市場概要、市場規模と予測、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 調査の目的と前提条件

第2章 市場の範囲

  • レポートの説明
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 主なハイライト
  • 製品発売
  • PEST分析
  • 規制シナリオ
  • 合併と買収

第4章 世界の消化性潰瘍治療薬市場:製品タイプ別

  • イントロダクション
  • プロトンポンプ阻害剤
  • P-CAB
  • 制酸剤
  • H2拮抗薬
  • 抗生物質
  • 潰瘍保護

第5章 世界の消化性潰瘍治療薬市場:疾患適応別

  • 胃炎
  • 胃潰瘍
  • 十二指腸潰瘍
  • 胃食道逆流症 (GERD)

第6章 世界の消化性潰瘍治療薬市場:流通チャネル別

  • 病院薬局
  • 民間診療所
  • ドラッグストア
  • 小売薬局
  • Eコマース

第7章 世界の消化性潰瘍治療薬市場:地域別

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋地域
  • 中東
  • アフリカ

第8章 競合情勢

  • 企業プロファイル
    • Daewoong Pharmaceutical Co., Ltd.
    • 武田薬品工業
    • Pfizer Inc.
    • AstraZeneca plc.
    • RedHill Biopharma
    • Cadila Healthcare Ltd.
    • Novitium Pharma LLC.
    • Boehringer Ingelheim GmbH
    • エーザイ
    • Yuhan Corporation
    • GlaxoSmithKline plc.

第9章 セクション

目次

Title:
Peptic Ulcer Drugs Market, By Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB), Antacids, H2- Antagonists, Antibiotics, Ulcer Protective), By Disease Indication (Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)), By Distribution Channel (Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce), By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

Peptic ulcers are also classed as stomach ulcers or gastric ulcers can cause abdominal pain and discomfort in the abdomen. There are two types of peptic ulcer found gastric ulcer and duodenal ulcer. Gastric ulcers are commonly found in the inner lining of the stomach whereas the duodenal ulcers are formed in small intestines. Peptic ulcers are caused due to reduction of mucus layer that protects the stomach from digestive juices. Major symptoms of peptic ulcers constitute of burping, nausea, vomiting, loss in appetite, and etc. The treatment of peptic ulcers depend on the type of ulcer and the treatment regime mostly comprises of proton pump inhibitors, and antibiotics.

Key features of the study::

  • This report provides in-depth analysis of the Peptic Ulcer Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Peptic Ulcer Drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Daewoong Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., Abbott Laboratories, AstraZeneca plc., RedHill Biopharma, Cadila Healthcare Ltd., Novitium Pharma LLC, Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, and GlaxoSmithKline plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Peptic Ulcer Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Peptic Ulcer Drugs market

Detailed Segmentation::

  • Peripheral Intravenous Catheter Market, By Product Type:
    • Proton Pump Inhibitors
    • Potassium-Competitive Acid Blocker (P-CAB)
    • Antacids
    • H2- Antagonists
    • Antibiotics
    • Ulcer Protective
  • Peripheral Intravenous Catheter Market, By Disease Indication:
    • Gastritis
    • Gastric Ulcer
    • Duodenal Ulcer
    • Gastroesophageal Reflux Disease (GERD)
  • Peripheral Intravenous Catheter Market, By Distribution Channel:
    • Hospital Pharmacies
    • Private Clinics
    • Drug Stores
    • Retail Pharmacies
    • E-Commerce
  • Peripheral Intravenous Catheter Market, By Region:
    • North America
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Daewoong Pharmaceutical Co., Ltd. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Takeda Pharmaceutical Co., Ltd.
    • Pfizer Inc.
    • AstraZeneca plc.
    • RedHill Biopharma
    • Cadila Healthcare Ltd.
    • Novitium Pharma LLC.
    • Boehringer Ingelheim GmbH
    • Eisai Co. Ltd.
    • Yuhan Corporation
    • GlaxoSmithKline plc.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippets, By Disease Indication
    • Market Snippets, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Peptic Ulcer Drugs Market, By Product Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Proton Pump Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Potassium-Competitive Acid Blocker (P-CAB)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Antacids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • H2- Antagonists
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Ulcer Protective
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global Peptic Ulcer Drugs Market, By Disease Indication, 2019 - 2027, (US$ Mn)

  • Gastitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Gastric Ulcer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Duodenal Ulcer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Gastroesophageal Reflux Disease (GERD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Peptic Ulcer Drugs Market, By Distribution Channel, 2019 - 2027, (US$ Mn)

  • Hospitals Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Private Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Drug Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • E-Commerce
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Peptic Ulcer Drugs Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Company Profiles
    • Daewoong Pharmaceutical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Takeda Pharmaceutical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca plc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • RedHill Biopharma
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cadila Healthcare Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novitium Pharma LLC.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eisai Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Yuhan Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.